Ajax-Loading

AbbVie Inc - Accumulated Depreciation

AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Accumulated-Depreciation" stands at 7.75 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

As of the end of AbbVie Inc's third quarter, the item "Accumulated Depreciation" stands at 7.75 Billion USD. This represents an increase of 1.24 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.52 percent compared to the value the year prior.
The 1 year change in percent is 8.52.
The 3 year change in percent is 33.87.

The Serie's long term average value is 6.30 Billion United States Dollars. It's latest available value, on 09/30/2025, is 23.04 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is +3,872,900.00%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Accumulated Depreciation for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Accumulated Depreciation905,699,262,464.00
LogoJohnson & Johnson - Accumulated Depreciation486,508,953,600.00
LogoRoche Holding AG - Accumulated Depreciation317,433,206,677.55
LogoAstraZeneca PLC - Accumulated Depreciation280,205,508,085.11
LogoNovartis AG - Accumulated Depreciation255,096,620,580.91